HC may take up Epharmacy ban

CHENNAI: Epharmacies have moved a division bench of the Madras High Court challenging a recent order banning sale of medicines online till the central health ministry formalises the regulatory environment for web-based drug aggregators.

Madras High Court judge Pushpa Sathyanarayana, on Monday, had imposed a restraint on online pharmacies from conducting their businesses and directed the Central Drugs Standard Control Organisation to notify necessary amendments on the Gazette before end of January next year. Against this order, online drug aggregators have litigated before a division bench of the Madras High Court.

“The court is expected to take up the matter on Thursday,” Chandra Kumar, counsellor for the Tamil Nadu Chemists and Druggists Organisation, said.

The TNCDA had won the ban on online sales on grounds that the businesses were operating without valid licences.

While imposing the ban, Madras High Court had faulted the central government for not putting out the final contours of the regulatory environment even after two years since a similar petition was filed with the Madras High Court.

Justice Sathyanarayana, in her order banning sales till January, said: “The central government had already been given a longer rope by the order of the division bench…” adding that the “rules are still at the draft stage” even though its has been two years since the judgement.

Netmeds, one of the respondents to the case, had argued that it was not “violating any law,” particularly ones concerning retail licensing and others. Practo had submitted that a “request for prescription drugs would be rejected, unless a valid prescription is uploaded with such request.”

  • Related Posts

    Unapproved drops for dry eyes pose risks: Govt

    NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unapproved drops for dry eyes pose risks: Govt

    Unapproved drops for dry eyes pose risks: Govt

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Govt highlights multi-layer framework to curb misleading advertisements

    Govt highlights multi-layer framework to curb misleading advertisements

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Study finds rising resistance to a last-resort antibiotic in Africa

    Study finds rising resistance to a last-resort antibiotic in Africa